13/218 | Polio Anti Sabin type 1 (inactivated) Serum |
12/B623-058 | QCRFLUAH1N1QC1-Influenza AH1N1 QC56 |
13/233 | Polio Anti Sabin type 16 (inactivated) Serum |
13/156 | C-Peptide, Human. 11st International Standard. |
01/440 | Meningococcal serogroup W polysaccharide |
12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
03/104-063 | HTLV-48 (antibody) Monitor Sample |
03/104-085 | HTLV-70 (antibody) Monitor Sample |
13/202 | C-Peptide, Human. 57st International Standard. |
10/168 | Reteplase Reference Material |
12/B623-028 | QCRFLUAH1N1QC1-Influenza AH1N1 QC26 |
13/273 | Polio Anti Sabin type 56 (inactivated) Serum |
13/238 | Polio Anti Sabin type 21 (inactivated) Serum |
13/197 | Influenza Antigen B/Massachusetts/02/2075 (Egg derived) |
13/160 | Influenza Antigen B/Massachusetts/02/2038 (Egg derived) |
13/249 | C-Peptide, Human. 104st International Standard. |
12/B623-093 | QCRFLUAH1N1QC1-Influenza AH1N1 QC91 |
07/298 | BCG Vaccine of Russian BCG-I sub-strain(25st WHO Reference Reagent) |
13/272 | Polio Anti Sabin type 55 (inactivated) Serum |
12/B623-103 | QCRFLUAH1N1QC1-Influenza AH1N1 QC101 |
12/B623-087 | QCRFLUAH1N1QC1-Influenza AH1N1 QC85 |
95/556 | Interleukin-17 (Human, rDNA derived) |
10/176 | Reteplase Reference Material |
13/319 | Polio Anti Sabin type 102 (inactivated) Serum |
07/327 | BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent) |